See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131324_2018_Genomic_Health_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.2094381642008752, 'aggregate_val': 371462000, 'exp_sum': 307136000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 76910000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 164779000, 'ResearchAndDevelopmentExpense': 64200000, 'remainder_Expenses': 1247000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001131324, Genomic Health INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 10,917,000 |
| 2 | AssetsCurrent | 174,260,000 |
| 3 | PropertyPlantAndEquipment | 46,440,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 39,516,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 72,670,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 157,001,000 |
| 15 | ResearchAndDevelopmentExpense | 62,811,000 |
| 16 | remainder_Expenses | 56,222,000 |
| 17 | remainder_Revenues | 340,750,000 |
| 18 | remainder_NetIncome | 4,097,000 |
| 19 | remainder_ComprehensiveNetIncome | -1,492,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 231,617,000 |
| 1 | Liabilities | 39,516,000 |
| 2 | Expenses | 348,704,000 |
| 3 | Revenues | 340,750,000 |
| 4 | StockholdersEquity | 192,101,000 |
| 5 | NetIncome | -3,857,000 |
| 6 | ComprehensiveNetIncome | -5,349,000 |
| 7 | BaseVar | 483,088,000 |
| 8 | EconomicCapitalRatio | 3.90 |
Edgar->Model Mapping
Feature Distribution
Change over Time
